Inhibikase Therapeutics (IKT) Stock Price & Financial Analysis
Inhibikase Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Inhibikase Therapeutics
What is the current stock price for IKT?
As of the latest trading session, IKT stock trades at $1.68. The 52-week range is $1.33–$2.27, with a day range of $1.57–$1.70.
What is the P/E ratio for IKT?
The P/E ratio (Price-to-Earnings) for IKT is shown in the Key Statistics section. This valuation metric helps compare Inhibikase Therapeutics, Inc. to industry peers.
Does IKT pay dividends?
Inhibikase Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for IKT?
Based on 1 analyst, the consensus for IKT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of IKT?
Inhibikase Therapeutics's market capitalization is $165.2M, classifying it as a micro-cap company. Inhibikase Therapeutics operates in the Healthcare sector within the Biotechnology industry.